G1 Therapeutics Inc. (GTHX)
NASDAQ: GTHX
· Real-Time Price · USD
7.16
0.01 (0.14%)
At close: Sep 17, 2024, 9:56 PM
G1 Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -5.47M | -10.22M | -10.88M | -18.2M | 8.71M | -27.59M | -33.65M | -25.27M | -39.45M | -49.19M | -40.02M | -42.47M | -39.42M | -26.44M |
Depreciation & Amortization | 121K | 120K | 124K | 127K | 130K | 132K | 137K | 139K | 139K | 115K | 114K | 117K | 118K | 120K |
Stock-Based Compensation | 2.09M | 2.55M | 3.21M | 3.65M | 3.81M | 3.84M | 4.4M | 4.79M | 5.64M | 5.76M | 5.21M | 5.53M | 5.69M | 5.89M |
Other Working Capital | -611K | -3.1M | -325K | -2.8M | -1.13M | 282K | 240K | 392K | 5.74M | 2.02M | 2M | 2.36M | -3.86M | 260K |
Other Non-Cash Items | 4.99M | 1.33M | -10.48M | 9.33M | 43K | 914K | 440K | 658K | 723K | 1.31M | 786K | 209K | 276K | 433K |
Deferred Income Tax | n/a | n/a | 10.25M | -9.67M | -584K | n/a | n/a | n/a | n/a | n/a | 362K | 82K | 98K | 48K |
Change in Working Capital | -2.64M | -1.5M | -5.02M | 4.18M | 1.98M | -6.34M | -1.96M | -1.56M | -5.61M | 3.82M | -1.11M | 2.45M | -3.25M | -6.93M |
Operating Cash Flow | -5.27M | -8.9M | -12.79M | -10.58M | 14.09M | -29.05M | -30.63M | -21.25M | -38.56M | -38.18M | -34.66M | -34.08M | -36.49M | -26.88M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -506K | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -36.47M | -17.21M | -47.15M | -12.3M | -40.15M | -25.09M | -35.36M | -29.66M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 36.7M | 22.5M | 39.5M | 19.5M | 40.5M | 28M | 15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 1K | -7.65M | 7.2M | 346K | 2.91M | -20.36M | -29.66M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 229K | 5.29M | -7.65M | 7.2M | 346K | 2.91M | -20.36M | -29.66M | -506K | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | 553K | -8.75M | 1K | -1.69M | -25M | n/a | n/a | n/a | n/a | n/a | 45M | n/a | n/a | 10M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -321K | 26K | -248K | 1.71M | -1.75M | -214K | -33K | 127K | n/a | 18K | -1.24M | 2.08M | 1.48M | 2.11M |
Financial Cash Flow | 232K | -8.72M | 34K | 22K | -26.75M | -214K | 52.35M | 127K | n/a | 18K | 43.76M | 2.08M | 1.48M | 98.54M |
Net Cash Flow | -4.81M | -12.33M | -20.41M | -3.35M | -12.32M | -26.36M | 1.36M | -50.78M | -39.06M | -38.17M | 9.1M | -32M | -35.01M | 71.66M |
Free Cash Flow | -5.27M | -8.9M | -12.79M | -10.58M | 14.09M | -29.05M | -30.63M | -21.25M | -39.06M | -38.18M | -34.66M | -34.08M | -36.49M | -26.88M |